Monday, August 31, 2026

Global Health & Pharma

1 article

GSK's Six-Monthly Asthma Biologic Could Reshape Treatment Standards From London to Lagos

GlaxoSmithKline is targeting a 2027 global launch for depemokimab, an ultra-long-acting biologic that could require just two injections per year — a potential game-changer for the millions of severe asthma patients worldwide who struggle with monthly treatment regimens. The drug enters a $164 billion market where patient adherence is a universal challenge, particularly acute in lower-resource healthcare systems. If validated, it could shift prescribing patterns across developed and emerging mark

ViaNews Editorial Team•Feb 18, 2026

What we know · the intelligence behind this page

Live from the substrate

What we're seeing

Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets

Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.

Our read on the data ›

Signals we're tracking

EPKINLY Regulatory-Clinical Success Cascade

High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.

Patterns we're watching ›

Where sources disagree

ING Group

Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.

We flag conflicts openly ›

Recently verified

✓ Checked against the original source

4,979

facts traced to their source — and we flag the ones that don't hold up.

101 entities tracked4,979 facts checked against source5,261 source documents archived

Query this data → isubstrate.com